Overall survival Hazard ratio (95%CI) | Progression-free survival Hazard ratio (95%CI) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Serum protein | Unadjusted | P value | q value | Adjusted | P value | q value | Unadjusted | P value | q value | Adjusted | P value | q value |
ADA | – | – | – | – | – | – | 2.13 (1.46–3.09) | < 0.0001 | 0.0067 | 2.39 (1.38–4.16) | 0.0020 | 0.1703 |
CASP8 | – | – | – | – | – | – | 1.65 (1.28–2.14) | 0.00012 | 0.0099 | 1.73 (1.25–2.39) | 0.00087 | 0.0786 |
CAIX | 1.56 (1.27–1.93) | < 0.0001 | 0.0017 | 1.44 (1.15–1.81) | 0.0018 | 0.1399 | – | – | – | – | – | – |
CD244 | 0.57 (0.35–0.95) | 0.030 | 0.9216 | 0.74 (0.37–1.49) | 0.40 | 0.9818 | 0.50 (0.31–0.79) | 0.0028 | 0.2250 | 0.50 (0.27–0.91) | 0.022 | 0.9819 |
CD8A | – | – | – | – | – | – | 0.91 (0.68–1.22) | 0.55 | 0.9899 | 0.97 (0.64–1.46) | 0.88 | 0.9819 |
CSF-1 | 11.16 (4.12–30.20) | < 0.0001 | 0.0002 | 6.05 (1.59–23.00) | 0.0083 | 0.5976 | 4.90 (2.24–10.68) | < 0.0001 | 0.0059 | 5.00 (1.61–15.54) | 0.0055 | 0.4584 |
FasL | 0.58 (0.40–0.83) | 0.0031 | 0.1862 | 0.47 (0.30–0.75) | 0.0013 | 0.1060 | – | – | – | – | – | – |
IL-6 | 1.37 (1.21–1.56) | < 0.0001 | < 0.0001 | 1.54 (1.14–2.10) | 0.0056 | 0.4126 | 1.26 (1.11–1.43) | 0.00029 | 0.0245 | 1.47 (1.11–1.93) | 0.0068 | 0.5677 |
IL-8 | 1.47 (1.31–1.66) | < 0.0001 | < 0.0001 | 1.63 (1.33–1.98) | < 0.0001 | 0.0002 | 1.35 (1.20–1.53) | < 0.0001 | 0.0001 | 1.44 (1.18–1.76) | 0.00034 | 0.0310 |
IL-10 | 1.41 (1.19–1.66) | < 0.0001 | 0.0058 | 1.42 (1.14–1.77) | 0.0019 | 0.1492 | 1.32 (1.11–1.56) | 0.0015 | 0.1176 | 1.35 (1.11–1.63) | 0.0025 | 0.2114 |
MCP2 | – | – | – | – | – | – | 0.89 (0.68–1.16) | 0.39 | 0.9899 | 0.88 (0.63–1.24) | 0.47 | 0.9819 |
MUC16 | 1.40 (1.22–1.61) | < 0.0001 | 0.0001 | 1.27 (1.05–1.55) | 0.015 | 0.9818 | 1.23 (1.08–1.39) | 0.0014 | 0.1157 | 1.22 (1.02–1.45) | 0.029 | 0.9819 |
TFNSFR4 | 1.78 (1.29–2.46) | 0.00043 | 0.0307 | 1.99 (1.23–3.23) | 0.0054 | 0.4062 | – | – | – | – | – | – |